SD Biosensor, Inc (KRX:137310)

Market Cap	1.16T
Revenue (ttm)	702.55B
Net Income (ttm)	188.00B
Shares Out	119.62M
EPS (ttm)	1,555.30
PE Ratio	6.21
Forward PE	n/a
Dividend	200.00 (2.07%)
Ex-Dividend Date	Dec 27, 2024

Volume	132,241
Average Volume	131,578
Open	9,890.00
Previous Close	9,900.00
Day's Range	9,650.00 - 10,040.00
52-Week Range	8,310.00 - 13,550.00
Beta	0.85
RSI	46.93
Earnings Date	Nov 7, 2025

About SD Biosensor

SD Biosensor, Inc, an in-vitro diagnostic company, provides point-of-care diagnostic solutions in South Korea and internationally. The company’s products include STANDARD Q, which provides various rapid test parameters comprising COVID-19 products and other parameters; STANDARD F, a multi-parametric and random accessible FIA system that provides diagnostic results to the laboratories; and STANDARD E, an enzyme linked immunosorbent assay for mass screening tests. Its products also include STANDARD M, a point-of-care MDx system for clinical decis...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2010
• Employees: 576
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 137310

Financial Performance

In 2024, SD Biosensor's revenue was 694.57 billion, an increase of 5.93% compared to the previous year's 655.68 billion. Losses were -98.41 billion, -78.96% less than in 2023.